AstraZeneca plc (LON:AZN) had its Overweight rating reiterated by Barclays

Analyst Ratings For AstraZeneca plc (LON:AZN)

Story continues below

Today, Barclays reiterated its Overweight rating on AstraZeneca plc (LON:AZN).

There are 9 Buy Ratings, 6 Hold Ratings, 3 Sell Ratings, no Strong Buy Ratings on the stock.

The current consensus rating on AstraZeneca plc (LON:AZN) is Hold with a consensus target price of GBX 7,062.50 per share, a potential .

Some recent analyst ratings include

  • 10/9/2019-AstraZeneca plc (LON:AZN) had its Overweight rating reiterated by Barclays
  • 10/8/2019-AstraZeneca plc (LON:AZN) had its Buy rating reiterated by Bank of America with a GBX 8,500 price target
  • 10/1/2019-AstraZeneca plc (LON:AZN) had its Reduce rating reiterated by HSBC with a GBX 5,180 price target
  • 9/30/2019-AstraZeneca plc (LON:AZN) had its Buy rating reiterated by Shore Capital

    Recent Trading Activity for AstraZeneca plc (LON:AZN)
    Shares of AstraZeneca plc closed the previous trading session at 7,064.00 up +55.00 0.78% with 43.47 shares trading hands.

    An ad to help with our costs